Colorectal Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Colorectal Cancer, including details on symptoms, genetics, screening, treatment, information.

Volume 4 (2007), Issue 12 (December)

1. Interaction of cigarette smoking with cyclooxygenase-2 on ulcerative colitis-associated neoplasia in mice.
   Cancer Invest, 25(8): 750-7. [Abstract] [Full-text]
2. Macrophage migration inhibitory factor in cancer.
   Cancer Invest, 25(8): 715-9. [Abstract] [Full-text]
3. Adjuvant therapy with raltitrexed in patients with colorectal cancer intolerant of 5-fluorouracil: British Columbia Cancer Agency experience.
   Cancer Invest, 25(8): 711-4. [Abstract] [Full-text]
4. Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors.
   Gastroenterology, 133(6): 1869-81. [Abstract] [Full-text]
5. Epigenetic and genetic alterations in Netrin-1 receptors UNC5C and DCC in human colon cancer.
   Gastroenterology, 133(6): 1849-57. [Abstract] [Full-text]
6. Predictive molecular markers for colorectal cancer patients with resected liver metastasis and adjuvant chemotherapy.
   Gastroenterology, 133(6): 1831-9. [Abstract] [Full-text]
7. Inactivation of the UNC5C Netrin-1 receptor is associated with tumor progression in colorectal malignancies.
   Gastroenterology, 133(6): 1840-8. [Abstract] [Full-text]
8. Translational approaches to addressing complex genetic pathways in colorectal cancer.
   Transl Res, 151(1): 10-6. [Abstract] [Full-text]
9. Identification and characterization of Asef2, a guanine-nucleotide exchange factor specific for Rac1 and Cdc42.
   Oncogene, 26(55): 7620-267. [Abstract] [Full-text]
10. Inhibitory effects of olive oil phenolics on invasion in human colon adenocarcinoma cells in vitro.
    Int J Cancer, 122(3): 495-500. [Abstract] [Full-text]
11. Dietary glycemic load, glycemic index and colorectal cancer risk: results from the Netherlands Cohort Study.
    Int J Cancer, 122(3): 620-9. [Abstract] [Full-text]
12. Oral contraceptive use, hormone replacement therapy, reproductive history and risk of colorectal cancer in women.
    Int J Cancer, 122(3): 643-6. [Abstract] [Full-text]
13. Kinetic analysis of butyrate transport in human colon adenocarcinoma cells reveals two different carrier-mediated mechanisms.
    Biochem J, 409(1): 311-20. [Abstract] [Full-text]
14. Meta-analysis of hepatic arterial infusion for unresectable liver metastases from colorectal cancer: the end of an era?
    J Clin Oncol, 25(35): 5649-54. [Abstract] [Full-text]
15. Ablative and catheter-delivered therapies for colorectal liver metastases (CRLM).
    Eur J Surg Oncol, 33: S64-75. [Abstract] [Full-text]
16. Computer-based decision making in medicine: A model for surgery of colorectal liver metastases.
    Eur J Surg Oncol, 33: S111-7. [Abstract] [Full-text]
17. Health-related quality of life as a valid outcome in the treatment of advanced colorectal cancer.
    Eur J Surg Oncol, 33: S95-104. [Abstract] [Full-text]
18. Factors that influence treatment strategies in advanced colorectal cancer.
    Eur J Surg Oncol, 33: S88-94. [Abstract] [Full-text]
19. Colorectal liver metastases: Radiological diagnosis and staging.
    Eur J Surg Oncol, 33: S5-16. [Abstract] [Full-text]
20. Resection of pulmonary metastases from colorectal carcinoma.
    Eur J Surg Oncol, 33: S59-63. [Abstract] [Full-text]
21. Treatment strategies for the management of advanced colorectal liver metastases detected synchronously with the primary tumour.
    Eur J Surg Oncol, 33: S76-83. [Abstract] [Full-text]
22. Treatment of advanced colorectal cancer in the elderly.
    Eur J Surg Oncol, 33: S84-7. [Abstract] [Full-text]
23. Extending the frontiers of resectability in advanced colorectal cancer.
    Eur J Surg Oncol, 33: S52-8. [Abstract] [Full-text]
24. Monoclonal antibodies in the treatment of advanced colorectal cancer.
    Eur J Surg Oncol, 33: S24-34. [Abstract] [Full-text]
25. Bringing unresectable liver disease to resection with curative intent.
    Eur J Surg Oncol, 33: S42-51. [Abstract] [Full-text]
26. Neoadjuvant treatment before resection of liver metastases.
    Eur J Surg Oncol, 33: S35-41. [Abstract] [Full-text]
27. The result of liver resection for colorectal metastases in a small volume hospital in western Norway.
    Eur J Surg Oncol, 33: S105-10. [Abstract] [Full-text]
28. Prolactinoma as the first manifestation of Gardner's syndrome.
    Pediatr Blood Cancer, 50(2): 409-12. [Abstract] [Full-text]
29. Mast cells are an essential hematopoietic component for polyp development.
    Proc Natl Acad Sci U S A, 104(50): 19977-82. [Abstract] [Full-text]
30. Pulmonary metastatic microangiopathy of colon cancer presenting as a "tree in bud" pattern.
    Br J Radiol, 81(961): e11-2. [Abstract] [Full-text]
31. Accuracy of CT prediction of poor prognostic features in colonic cancer.
    Br J Radiol, 81(961): 10-9. [Abstract] [Full-text]
32. Previous cancer screening behavior as predictor of endoscopic colon cancer screening among women aged 50 and over, in NYC 2002.
    J Community Health, 33(1): 10-21. [Abstract] [Full-text]
33. Has the surge in media attention increased public awareness about colorectal cancer and screening?
    J Community Health, 33(1): 1-9. [Abstract] [Full-text]
34. Adjuvant chemotherapy versus observation in patients with colorectal cancer: a randomised study.
    Lancet, 370(9604): 2020-9. [Abstract] [Full-text]
35. Folylpolyglutamate synthase and gamma-glutamyl hydrolase regulate leucovorin-enhanced 5-fluorouracil anticancer activity.
    Biochem Biophys Res Commun, 365(4): 801-7. [Abstract] [Full-text]
36. A second liver resection due to recurrent colorectal liver metastases.
    Arch Surg, 142(12): 1144-9; discussion 1150. [Abstract] [Full-text]
37. Colorectal carcinoma in childhood and adolescence: a clinicopathologic review.
    J Clin Oncol, 25(36): 5808-14. [Abstract] [Full-text]
38. Predicting response to radioimmunotherapy from the tumor microenvironment of colorectal carcinomas.
    Cancer Res, 67(24): 11896-905. [Abstract] [Full-text]
39. Flat colorectal cancers are genetically determined and progress to invasion without going through a polypoid stage.
    Cancer Res, 67(24): 11594-600. [Abstract] [Full-text]
40. Discovery of epigenetically silenced genes by methylated DNA immunoprecipitation in colon cancer cells.
    Cancer Res, 67(24): 11481-6. [Abstract] [Full-text]
41. Aberrant expression of selenoproteins in the progression of colorectal cancer.
    Cancer Lett, 259(2): 218-30. [Abstract] [Full-text]
42. CT colonography for incomplete or contraindicated optical colonoscopy in older patients.
    AJR Am J Roentgenol, 190(1): 145-50. [Abstract] [Full-text]
43. Side-hole catheter placement for hepatic arterial infusion chemotherapy in patients with liver metastases from colorectal cancer: long-term treatment and survival benefit.
    AJR Am J Roentgenol, 190(1): 111-20. [Abstract] [Full-text]
44. Narrow band imaging for colonoscopic surveillance in hereditary non-polyposis colorectal cancer.
    Gut, 57(1): 65-70. [Abstract] [Full-text]
45. A prospective randomised study on narrow-band imaging versus conventional colonoscopy for adenoma detection: does narrow-band imaging induce a learning effect?
    Gut, 57(1): 59-64. [Abstract] [Full-text]
46. Somatic APC mosaicism: an underestimated cause of polyposis coli.
    Gut, 57(1): 71-6. [Abstract] [Full-text]
47. Is early-onset microsatellite and chromosomally stable colorectal cancer a hallmark of a genetic susceptibility syndrome?
    Int J Cancer, 122(4): 796-801. [Abstract] [Full-text]
48. Helicobacter hepaticus promotes azoxymethane-initiated colon tumorigenesis in BALB/c-IL10-deficient mice.
    Int J Cancer, 122(4): 832-8. [Abstract] [Full-text]
49. Advances in minimally invasive surgery in the treatment of colorectal cancer.
    Expert Rev Anticancer Ther, 8(1): 111-23. [Abstract] [Full-text]
50. Which patients will benefit from percutaneous radiofrequency ablation of colorectal liver metastases? Critically appraised topic.
    Abdom Imaging, 33(1): 48-53. [Abstract] [Full-text]
51. Digital fecal occult blood testing in the ambulatory urology clinic.
    J Am Coll Surg, 206(1): 144-7. [Abstract] [Full-text]
52. Addition of bevacizumab to irinotecan- and oxaliplatin-based preoperative chemotherapy regimens does not increase morbidity after resection of colorectal liver metastases.
    J Am Coll Surg, 206(1): 96-106. [Abstract] [Full-text]
53. Patients' preferences for low rectal cancer surgery.
    Eur J Surg Oncol, 34(1): 42-8. [Abstract] [Full-text]
54. Hypermethylation status of APC inversely correlates with the presence of submucosal invasion in laterally spreading colorectal tumors.
    Mol Carcinog, 47(1): 1-8. [Abstract] [Full-text]
55. Elevated preoperative neutrophil to lymphocyte ratio predicts survival following hepatic resection for colorectal liver metastases.
    Eur J Surg Oncol, 34(1): 55-60. [Abstract] [Full-text]
56. Common genetic variants at the CRAC1 (HMPS) locus on chromosome 15q13.3 influence colorectal cancer risk.
    Nat Genet, 40(1): 26-8. [Abstract] [Full-text]

© 2004-2008 Colorectal Cancer Research Today. All Rights Reserved.